Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Christopher

Showing results (401-410 of 445) with videos related to

Pageof 45
Sort By:
Cell|March 12, 2017
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO MutationAh Ram Kim, Jacob C Ulirsch, Stephan Wilmes, et al.
Nature|December 8, 2022
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptidesXinbo Yang, Lee I Garner, Ivan V Zvyagin, et al.
Immunity|December 13, 2023
Stat5 opposes the transcription factor Tox and rewires exhausted CD8<sup>+</sup> T cells toward durable effector-like states during chronic antigen exposureJean-Christophe Beltra, Mohamed S Abdel-Hakeem, Sasikanth Manne, et al.
Cell Reports|May 18, 2017
The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 LigandsHugo G Hilton, Curtis P McMurtrey, Alex S Han, et al.
Blood|December 23, 2022
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivoTeresa L Ramos, Sara Bolivar-Wagers, Sujeong Jin, et al.
Cell|July 28, 2018
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC BindingLeah V Sibener, Ricardo A Fernandes, Elizabeth M Kolawole, et al.
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Cell|December 26, 2017
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating LymphocytesMarvin H Gee, Arnold Han, Shane M Lofgren, et al.
The Journal of Experimental Medicine|December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Pageof 45

Showing results (401-410 of 445) with videos related to

Sort By:
Pageof 45
Cell|March 12, 2017
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO MutationAh Ram Kim, Jacob C Ulirsch, Stephan Wilmes, et al.
Nature|December 8, 2022
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptidesXinbo Yang, Lee I Garner, Ivan V Zvyagin, et al.
Immunity|December 13, 2023
Stat5 opposes the transcription factor Tox and rewires exhausted CD8<sup>+</sup> T cells toward durable effector-like states during chronic antigen exposureJean-Christophe Beltra, Mohamed S Abdel-Hakeem, Sasikanth Manne, et al.
Cell Reports|May 18, 2017
The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 LigandsHugo G Hilton, Curtis P McMurtrey, Alex S Han, et al.
Blood|December 23, 2022
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivoTeresa L Ramos, Sara Bolivar-Wagers, Sujeong Jin, et al.
Cell|July 28, 2018
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC BindingLeah V Sibener, Ricardo A Fernandes, Elizabeth M Kolawole, et al.
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Cell|December 26, 2017
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating LymphocytesMarvin H Gee, Arnold Han, Shane M Lofgren, et al.
The Journal of Experimental Medicine|December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Pageof 45